ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2026
Bioadhesive Hydrogel With Polyphenol-Armored Nanogene Rejuvenates Chondrocyte Senescence for Aged Osteoarthritis Therapy.
Article in Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Advances in Injectable miRNA-Loaded Nanocomposite Hydrogel Systems for Cartilage Repair in KOA.International journal of nanomedicine · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
Abstract
Chondrocyte senescence, exacerbated by ageing and cellular stress, is a key driver of metabolic imbalance during aged osteoarthritis (OA) progression. Achieving sustained inhibition of chondrocyte senescence while mitigating multifactorial cellular stressors remains challenging in aged OA treatment. In this study, an injectable bioadhesive and lubricating hydrogel, encapsulating miR-140-5p (miR-140)-loaded and polyphenol-armored nanoparticles, was developed for rejuvenating senescent chondrocytes in aged OA. Originating from catechol groups, the hydrogel anchors firmly to cartilage tissues, facilitating a sustained reduction in joint friction. It also acts as a local depot for nanoparticles, prolonging their retention within the harsh joint cavity. The polyphenol armor on the nanoparticles preserves miR-140 activity in the RNase- and ROS-rich senescence microenvironment, prevents premature leakage, and enhances transfection efficiency by overcoming extracellular matrix, cell membrane, and lysosomal barriers. This contributes to the downregulation of senescence-associated signaling pathways in chondrocytes. Furthermore, the polyphenol armor exhibits catalase- and superoxide-dismutase-like activity, mitigating mitochondrial dysfunction through targeted ROS scavenging. By integrating these advanced attributes, the hydrogel attenuated chondrocyte senescence and OA progression in an aged rat model, showing great prospects in clinical application.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.